Ethics Transparency

Ethics & Transparency

Our Approach to
Ethics & Transparency

Our Approach to
Ethics & Transparency
Ethics & Transparency

The foundation of our strategy is our unwavering commitment to values and integrity.

All employees are expected to behave ethically and in compliance with our Code of Conduct and policies. Our Code of Conduct, Our Values and Standards, is the foundation of our company’s ethics and compliance program.

We aspire to be the most trusted healthcare company in the world. Our values and standards are an essential part of how we build trust and confidence with customers, partners, employees, the general public and other stakeholders. We’re working every day to earn trust by engaging audiences on all sides of the issues that matter, and by going beyond mandatory disclosure to proactively communicate key information in greater detail.

We disclose information through our financial and corporate responsibility reporting, through participation in voluntary efforts such as CDP, through the media, and through one-on-one stakeholder discussions.

Ethics and compliance training is an important part of creating a strong culture. The Global Compliance Training Series (GCTS) portfolio of required fundamental courses helps build awareness of the company’s Code of Conduct, policies, and the legal and regulatory requirements applicable to our business. The GCTS courses are mandatory for targeted employees.

Compliance

As part of our long-standing commitment to ethics and good corporate citizenship, we adopt policies and procedures to facilitate compliance with the laws and regulations that govern the way we market and sell our medicines, vaccines and other products.

 

We have a well-established global compliance program that is consistent with the International Federation of Pharmaceutical Manufacturers & Associations (IFPMA) Code of Practice requirements, as well as other applicable regional or country industry codes of conduct, including those issued by the Pharmaceutical Research and Manufacturers of America (PhRMA) and the European Federation of Pharmaceutical Industry Associations (EFPIA).

Our global compliance program is built around the core elements of an effective compliance program.

Our company’s Board of Directors and senior management, including the chief ethics and compliance officer and members of the Corporate Compliance Committee, provide the foundational elements of leadership, accountability and structure to oversee the company’s global compliance program. Written standards, including our Code of Conduct, compliance-related policies and procedures; education; training; and communications; reinforce the importance of ethical and compliant business practices.

The Corporate Compliance Committee meets at least four times a year to review the compliance status across the company’s business divisions worldwide as part of the committee’s effort to assess the effectiveness of the company’s compliance program.